A review of Streptococcus pneumoniae infection treatment failures associated with fluoroquinolone resistance

被引：123
作者：
Fuller, JD
Low, DE
机构：
[1] Mt Sinai Hosp, Dept Microbiol, Toronto, ON M5G 1X5, Canada
[2] Toronto Med Labs, Dept Microbiol, Toronto, ON, Canada
[3] Univ Toronto, Toronto, ON, Canada
来源：
CLINICAL INFECTIOUS DISEASES | 2005年 / 41卷 / 01期
关键词：
D O I：
10.1086/430829
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
We reviewed all of the published reports of cases of fluoroquinolone treatment failures for respiratory tract infection due to fluoroquinolone-resistant Streptococcus pneumoniae. There were 20 ciprofloxacin and levofloxacin treatment failures reported. Physicians should be aware, when treating pneumococcal respiratory tract infections in older patients with a fluoroquinolone, that clinical failures might occur, especially for patients with comorbid illnesses and a history of recent fluoroquinolone use.
引用
收藏
页码：118 / 121
页数：4
相关论文
共 32 条
  • [1] Fluoroquinolone-resistant Streptococcus pneumoniae, an emerging but unrecognized public health concern:: Is it time to resight the goalposts?
    Ambrose, PG
    Bast, D
    Doern, GV
    Iannini, PB
    Jones, RN
    Klugman, KP
    Low, DE
    [J]. CLINICAL INFECTIOUS DISEASES, 2004, 39 (10) : 1554 - 1556
  • [2] Pharmacodynamics of fluoroquinolones against Streptococcus pneumoniae in patients with community-acquired respiratory tract infections
    Ambrose, PG
    Grasela, DM
    Grasela, TH
    Passarell, J
    Mayer, HB
    Pierce, PF
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (10) : 2793 - 2797
  • [3] Emergence of levofloxacin-resistant pneumococci in immunocompromised adults after therapy for community-acquired pneumonia
    Anderson, KB
    Tan, JS
    File, TM
    DiPersio, JR
    Willey, BM
    Low, DE
    [J]. CLINICAL INFECTIOUS DISEASES, 2003, 37 (03) : 376 - 381
  • [4] Worldwide incidence, molecular epidemiology and mutations implicated in fluoroquinolone-resistant Streptococcus pneumoniae:: data from the global PROTEKT surveillance programme
    Canton, R
    Morosini, M
    Enright, MC
    Morrissey, I
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 52 (06) : 944 - 952
  • [5] Brief report: Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia.
    Davidson, R
    Cavalcanti, R
    Brunton, JL
    Bast, DJ
    de Azavedo, JCS
    Kibsey, P
    Fleming, C
    Low, DE
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (10) : 747 - 750
  • [6] Empey PE, 2001, ANN PHARMACOTHER, V35, P687
  • [7] Risk factors for acquisition of levofloxacin-resistant Streptococcus pneumoniae:: A case-control study
    Ho, PL
    Tse, WS
    Tsang, KWT
    Kwok, TK
    Ng, TK
    Cheng, VCC
    Chan, RMT
    [J]. CLINICAL INFECTIOUS DISEASES, 2001, 32 (05) : 701 - 707
  • [8] Emerging mechanisms of fluoroquinolone resistance
    Hooper, DC
    [J]. EMERGING INFECTIOUS DISEASES, 2001, 7 (02) : 337 - 341
  • [9] The activity of levofloxacin and other antimicrobials against clinical isolates of Streptococcus pneumoniae collected worldwide during 1999-2002
    Jones, ME
    Blosser-Middleton, RS
    Thornsberry, C
    Karlowsky, JA
    Sahm, DF
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2003, 47 (04) : 579 - 586
  • [10] Prevalence and antimicrobial susceptibilities of bacteria isolated from blood cultures of hospitalized patients in the United States in 2002
    Karlowsky J.A.
    Jones M.E.
    Draghi D.C.
    Thornsberry C.
    Sahm D.F.
    Volturo G.A.
    [J]. Annals of Clinical Microbiology and Antimicrobials, 3 (1)
1234